Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Clinical trial NCT00201734 · TERMINATED

Trial details

NCT number: NCT00201734
Sponsor: Ohio State University Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tumors Unknown Primary Tumors Adenocarcinoma

Start date: 2005-06-01
Primary completion: 2007-11-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.